C. Haug et al., EFFECT OF CORTICOTROPIN-RELEASING FACTOR ON ATRIAL-NATRIURETIC-PEPTIDE RELEASE FROM THE ISOLATED-PERFUSED RAT-HEART, Arzneimittel-Forschung, 44-1(5), 1994, pp. 579-582
The effect of corticotropin releasing factor (CRF) on atrial natriuret
ic peptide (ANP) release and its possible modulation by indometacin, n
orepinephrine, propranolol and nitro-L-arginine (an inhibitor of the e
ndothelium-derived relaxing factor (EDRF) release) was investigated, u
sing an isolated perfused rat heart preparation. Bolus injection of 5
mu g CRF, dissolved in 100 mu l perfusion buffet, provoked a significa
nt (p < 0.01 vs. control) short-time increase of ANP release. Indometa
cin (3 x 10(-5) mol/l) inhibited the CRF-stimulated increase of ANP re
lease and decreased the basal ANP secretion (p < 0.01 vs. CRF group).
Norepinephrine (10(-9) mol/l slightly, but not significantly, decrease
d the CRF-stimulated ANP release and did not change the basal ANP outp
ut. Propranolol (3 x 10(-6) mol/l) did not alter ANP release. Nitro-L-
arginine (3 x 10(-5) mol/l) increased the basal ANP release (p < 0.01
vs. CRF group) and prolonged the CRF-induced rise of the ANP secretion
. The present data suggest that prostaglandins are important mediators
of basal and CRF-stimulated ANP release and that EDRF might be a phys
iological inhibitor of ANP release.